SEC Form 4 · accession 0001358403-17-000079
BELLICUM PHARMACEUTICALS, INC · BLCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan A Musso
Officer — CFO and Treasurer
Period of report
May 25, 2017
Accepted (ET)
May 26, 2017 · 3:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358403
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | May 25, 2017 | S | 6,311 | $12.2411 | D | 54,908 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares sold to satisfy tax liabilities and withholding obligations in connection with vesting of 14,706 shares of common stock from the Restricted Stock Awards granted to the Reporting Person on December 17, 2014.
- F2Includes 671 shares acquired under the Issuer's Employee Stock Purchase Plan on December 9, 2016.